Cochlear Limited (CHEOF)
OTCMKTS · Delayed Price · Currency is USD
197.00
-3.37 (-1.68%)
Sep 9, 2025, 1:53 PM EDT
Cochlear Market Cap
Cochlear has a market cap or net worth of $12.88 billion as of September 10, 2025. Its market cap has decreased by -2.98% in one year.
Market Cap
12.88B
Enterprise Value
12.85B
Revenue
1.54B
Ranking
n/a
PE Ratio
50.50
Stock Price
$197.00
Market Cap Chart
Since December 12, 1995, Cochlear's market cap has increased from 32.71M to 12.88B, an increase of 39,259.12%. That is a compound annual growth rate of 22.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 9, 2025 | 12.88B | 9.70% |
| Dec 31, 2024 | 11.74B | -11.97% |
| Dec 29, 2023 | 13.33B | 46.11% |
| Dec 30, 2022 | 9.13B | -11.71% |
| Dec 31, 2021 | 10.34B | 7.83% |
| Dec 31, 2020 | 9.59B | 4.99% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 982.68M |
| Veradigm | 825.37M |
| Elite Pharmaceuticals | 749.52M |
| Tian'an Technology Group | 705.53M |
| Glass House Brands | 600.85M |
| HealthLynked | 499.79M |
| CytoDyn | 396.74M |
| Northwest Biotherapeutics | 376.41M |